Evaluation of the novel vaginal contraceptive agent PPCM in preclinical studies using sperm hyaluronan binding and acrosome status assays.
Barbara B NorthMary B WeitzelDonald P WallerWilliam X BirchKenneth A FeathergillLynn A BirchChristopher J De JongeGail S PrinsPublished in: Andrology (2021)
PPCM vaginal gel may provide contraceptive protection as well as help with STI prevention. HBA may be a sensitive and much needed biomarker for sperm activity in future contraceptive development.